GILD - CIK 0000882095
GILEAD SCIENCES, INC. (GILD) reported revenue of $28.75B for fiscal year 2024, up 6.0% from $27.12B in fiscal 2023. The figure comes from the company's audited annual report as filed with the SEC.
| Quarter | Period end | revenue |
|---|---|---|
| Q1 | 2024-03-31 | $6.69B |
| Q2 | 2024-06-30 | $6.95B |
| Q3 | 2024-09-30 | $7.54B |
Calendar quarters as standardized by SEC XBRL frames; the company's fiscal calendar may offset from calendar quarters.
GILEAD SCIENCES, INC. (GILD) reported revenue of $28.75B for fiscal year 2024, up 6.0% from $27.12B in fiscal 2023. The figure comes from the company's audited annual report as filed with the SEC.
In the following fiscal year (2025), GILEAD SCIENCES, INC. reported revenue of $29.44B, an increase from the $28.75B reported in fiscal 2024.
See the full GILD revenue history or the complete income statement.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.